Updated:
HM Capital
HM Capital is a Beijing-based venture and private equity firm investing in early-to-growth-stage Chinese technology companies.
HM Capital
HM Capital is a Beijing-based private equity and venture capital firm active across the early-stage and growth-stage technology investment landscape in China. The firm operates with a generalist venture mandate, deploying capital from seed and start-up phases through expansion and late-stage growth, primarily targeting enterprise software, industrial technology, and digital health companies. Its investment model spans venture (general) and growth equity, reflecting the blurred lines common in China's tech-investing ecosystem where firms routinely follow portfolio companies from founding through pre-IPO rounds. The firm's strategy centers on direct equity investments into privately held Chinese technology companies, with check sizes and stage preferences adapting across the seed-to-growth spectrum. HM Capital's approach draws on the dense Beijing tech corridor, where proximity to founders, research institutions, and policy signals gives local investors an information advantage. While specific portfolio names and co-investors are not publicly disclosed, the firm's stated focus areas — enterprise software, AI/ML, digital health, and industrial tech — align with sectors that have attracted sustained policy support and venture funding in China. The firm does not publicly flag any explicit sector exclusions, suggesting a posture of broad technology coverage. Team size and total deployment figures remain undisclosed. HM Capital's website offers no public biographies, investment committee details, or structured vehicle descriptions, which is consistent with many smaller China-based asset managers that limit public disclosure to regulatory filings. No recent operational events — fund closes, promotions, office openings, or major deal announcements — have been sourced from public record or the firm's own communications as of mid-2026. The firm's network and operational footprint appear concentrated in Beijing, with no additional offices identified. Structurally, HM Capital's limited public disclosure reflects the broader opacity of China's private equity middle-market, where many firms operate without the reporting requirements or marketing infrastructure common among US- or Europe-domiciled GPs. For allocators, the firm represents a direct, Beijing-anchored exposure to China's early-to-growth-stage venture ecosystem, but due diligence would require direct engagement to assess team depth, track record, and governance — information not available from public sources.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Sector focus
Frequently asked questions
What investment stages does HM Capital target?
HM Capital invests across the full venture lifecycle, from seed and start-up rounds through expansion and late-stage growth. This stage-agnostic approach means the firm can deploy initial checks at formation and follow portfolio companies through subsequent funding rounds, a structure common among China-based venture firms that prize long-term founder relationships. The firm does not publicly differentiate its seed-stage and growth-stage teams or vehicles.
Which sectors does HM Capital explicitly avoid?
HM Capital has not publicly identified any sectors it explicitly excludes from its investment mandate. Its stated focus areas — enterprise software, AI/ML, digital health, and industrial technology — signal where the firm concentrates its sourcing and underwriting resources, but the absence of negative sector flags suggests the partnership retains discretion to evaluate opportunities outside these areas in China's technology market.
How does HM Capital source deal flow?
HM Capital's deal-sourcing model is not publicly described, but the firm's Beijing headquarters positions it in China's densest concentration of technology founders, venture networks, and policy institutions. For China-based early-stage investors, sourcing typically depends on founder referrals, university spinout relationships, and proximity to state-backed incubation programs — structural advantages that Beijing-anchored firms exploit. Allocators would need direct conversations to understand HM Capital's specific origination funnel.
Is HM Capital structured as a domestic RMB fund, a USD fund, or both?
HM Capital has not publicly disclosed its fund currency or legal structure. Many Beijing-based private equity firms operate parallel RMB and USD vehicles, but no public filings, LP disclosures, or the firm's limited website content confirm the structure for HM Capital. Determining currency exposure and vehicle domicile would require direct due diligence with the firm.
Who runs investment decisions at HM Capital?
HM Capital does not publicly list its investment committee members, managing partners, or senior investment professionals on its website or through public regulatory filings. The firm's leadership structure is not available from public record, which is not unusual for smaller, privately held Chinese asset managers that limit disclosure. Allocators would need to engage directly to assess decision-making authority and team composition.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: